Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1975-3-18
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0360-263X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
2
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1073-8
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:4155048-Anti-Anxiety Agents,
pubmed-meshheading:4155048-Benzodiazepines,
pubmed-meshheading:4155048-Heroin Dependence,
pubmed-meshheading:4155048-Humans,
pubmed-meshheading:4155048-Maryland,
pubmed-meshheading:4155048-Mass Screening,
pubmed-meshheading:4155048-Methadone,
pubmed-meshheading:4155048-Methaqualone,
pubmed-meshheading:4155048-Methods,
pubmed-meshheading:4155048-Regional Medical Programs
|
| pubmed:year |
1973
|
| pubmed:articleTitle |
Detection of the use of methaqualone and benzodiazepines in urine screening programs.
|
| pubmed:publicationType |
Journal Article
|